 

UUID:Aglgxb‘ie-1751-u48EB-BBP5C-R-85019156538e5dact [

lllll ||l||||||||||||l||ll||l|ll||||l||l||l||ll|l||l|l|l|ll|||l|

l ||||||||| |||||||||| |||I|l llllllllll L
l | #_J

I
II ||Illll|||||llIllllI||||||||||||||||||||||IllllllI IIlllllllI

I
Clinical Case Report
(For Collection of Cancerous Tissue)

0W, SW cou— N05
8070/3;

ICOiOvb

Sift.“ WX‘NOS 055-?

#0 77M” [Informed Consenlj

 

I personally informed this patient that a specimen(s) would be collected to be used for research
purposes. I reviewed the RESEARCH SUBJECT INFORMATION AND CONSENT
FORM with the patient and answered any questions the patient had. The patient then signed the
consent form as a free and voluntary act. A copy of this informed consent document will be retained at

our institution.

 

Name of Physmlan or away Codrdinator 'Signature Date

 

Elinical Information]

GENERAL TION

a Single No Married

Gender 0 Divorced Cl Widow Blood l’ressure Heart Rate
Cl Male emale

 

 

HISTORY OF PRESENT ILLNESS ,

 

Chief Complaints: Abate—1W ”a? m m0 brﬁae Aim; ) W

 

Symptoms: We; 6%)}, Co 9 S .

 

Clinical Findings:

 

Performance Scale (Karnofsky Score):
a 100 Asymptomatic )af80-90 Symptomatic but Fully Ambulatory 0 60-70 Symptomatic, in bed less than 50% of day
0 40-50 symptomatic, in bed more than 50% of day, but not bed ridden El 2030 Bed Ridden

 

 

 

CURRENT MEDICATIONS
Route

 

PAST MEDICAL HISTORY
Disorder

Treatment

Status

 

 

 

 

 

 

 

OBIGYN HISTORY .
Menopausal Status Date of Flrstﬁenses # of Pregnancies
in Pre-menopausal . > I
D Peri-Menopausal Date of Last Menses # of Live Births

El Post-menopausal

 

 

 

 

Birth Control: 0 Condom gl-Oral Contraceptive El IUD

D Other:

 

n Hormone Replacement

Therapy:

 

SOCIAL HISTORY

H

Alcohol

FAMILY MEDICAL-HISTORY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

LAB DATA "

Test Result L Date 1 1 Test Result Date
HIV \pNegative Cl Positive: CEA El Negative Cl Positive:

Hep B F’Negatlve El Positive: CA 15-3 0 Negative :1 Positive:

Hep C )3 Negative El Positive: CA 199 O Negative [3 Positive:
AFP Cl Negative El Positive: PSA El Negative El Positive:

Other: Cl Negative Cl Positive: Other: I: Negative [1 Positive:

B/T Cell Markers:

 

 

 

DIAGNOSTIC STUDIES

CLINICAL DIAGNOSIS

Involved L

Date of Diaonosis
T ,2 N M a Stage: 11! ,3

 

 

Wreatment Informatiﬂ

SURGICAL TREATMENT
Date of Procedure

Tumor

of

Nodes
Location of l.

Palpabie, Non-Dissected Lymph Nodes
Dissected Lymph Nodes
Distant Metastasis

Location

 

Collected by: __

Preserved by: __

F
Diseased Normal

to LNI

Pathology Form

 

[Specimen Infomationl

Date: _Time:_

 

 

Date: ,Time

SPECIMEN #' of
Parafﬁn Block Slide
Normal Diseased Diseased Normal
1 Qt
Time to Formaiin Time to ' ' -
min

PATHOLOGICAL DESCRIPTION

Tumor
of Tumor

,-

X

Nodes
# Examined

Distant Metastasis
Detailed

 

CONSOLIDATED DIAGNOSTIC PATHOLOGY FORM*

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Microscopic Appearance:
1. Histological pattern:
CELL DISTRIBUTION + - STRUCTURAL PATTERN + ~
Diffuse _ Streaming
Mosaic (Y " Storiform
Necrosis X Fibrosis
Lymghocytic Inﬁltration R PalisadinL
Vascular Invasion Cystic Degeneration
Clusterized R BleedgL
Alveolar Formation X Myxoid Change
Indian File d Psammoma/Calciﬁcation
2. Cellular features:
Squamous + - Adenomatous + - Sarcomstous + - Lymphomatous + -
Squamoid Cell 1/ Glandular cell Round Cell LargeCell
Spindle Cell " Cell Stratiﬁcation Fibroblast Small Cell
Kerstin 3 Secretion Osteoblast RS Cell/RS Like
Desmosome D(Intracyt. Vacuole Lipoblast Inﬂam. Cell
Pearl Q’Gland formation Myoblast Plasma Cell
Otherwise Speciﬁed: if?!) >
D, W

2. Cellular Differentiation.
Well Moderately Ppor

/

 

 

 

 

 

 

 

3. NuclearA

Nuclear
Anise Nucleosis

Nucleolar Prominent
Multinucleated Giant Cell
Mitotic
Nuclear Grade

Histological Diagnosis: ﬁgmﬁﬂam (2Q (age/54:034. 5‘ 9

Cements: Q, [[4 , Mm]: £14 (ﬁléou/YY
‘ mil)"; (”Q/[74W mf/ﬁ/QW L/U

 

Date

*(INTEGRATED REPORT OF FINDINGS BY CONTRIBUTOR AND ’ATHOLOGIST STAFF FOR RESEARCH USE ONL Y).

 

